Skip to main content
OpenTrials

Clinical trial condition

Prostatic Neoplasms

Explore clinical trials studying Prostatic Neoplasms. Study availability and eligibility vary by location and protocol.

35 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Neoplasms trial results

Recruiting

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT07225946

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Arizona Clinical Trials Chandler, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • MemorialCare Orange Coast Medical Center Fountain Valley, California, United States
  • University Of California San Diego La Jolla, California, United States
View all 150 locations
View Trial Details
Recruiting

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.

NCT07717268

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Hospital Universitario Miguel Servet Zaragoza, Aragon, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Instituto Catalán de Oncología Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Basurto Bilbao, Basque Country, Spain
View all 15 locations
View Trial Details
Recruiting

A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)

NCT06863272

Conditions
Castration-Resistant Prostatic Cancer, Genital Diseases, Genital Diseases, Male, +14 more
Locations
  • UCLA Hematology & Oncology ( Site 0003) Los Angeles, California, United States
  • University of California-Irvine Medical Center ( Site 0016) Orange, California, United States
  • UCSF Medical Center at Mission Bay ( Site 0034) San Francisco, California, United States
  • MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026) Washington D.C., District of Columbia, United States
View all 82 locations
View Trial Details
Recruiting

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

NCT07258407

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • Peter MacCallum Cancer Centre Melbourne, Victoria, Australia
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Institut Bergonié Bordeaux, France
View Trial Details
Recruiting

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

NCT06353386

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • UCSD Moores Cancer Center ( Site 0039) La Jolla, California, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0044) Los Angeles, California, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center-Cancer Research Services ( Site 0051) Miami, Florida, United States
  • University of Maryland-Greenebaum Comprehensive Cancer Center ( Site 0049) Baltimore, Maryland, United States
View all 77 locations
View Trial Details
Recruiting

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

NCT04868604

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • East Jefferson General Hospital River Ridge, Louisiana, United States
  • BAMF Health Grand Rapids, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START-New York Long Island Lake Success, New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details

Related conditions